SELLAS Life Sciences (SLS) Shares Outstanding (2010 - 2026)

SELLAS Life Sciences (SLS) has 17 years of Shares Outstanding data on file, last reported at $181.3 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $181.3 million, up 99.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $181.3 million (up 99.49% YoY), and the FY2025 annual result was $153.1 million, up 106.96% from the prior year.
• Shares Outstanding advanced to $181.3 million in Q1 2026 per SLS's latest filing, from $153.1 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $181.3 million in Q1 2026 and troughed at $15.9 million in Q1 2022.
• A 5-year average of $64.6 million and a median of $56.3 million in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding increased 5.44% in 2022, then surged 130.22% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $21.0 million in 2022, then jumped by 52.97% to $32.1 million in 2023, then surged by 130.22% to $74.0 million in 2024, then soared by 106.96% to $153.1 million in 2025, then increased by 18.44% to $181.3 million in 2026.
• Business Quant data shows SLS's Shares Outstanding at $181.3 million in Q1 2026, $153.1 million in Q4 2025, and $125.1 million in Q3 2025.